PROFIL KLINIS, LABORATORIS, MORBIDITAS DAN MORTALITAS PADA PASIEN INFEKSI VIRUS DENGUE PASCA COVID-19 DI RSUD DR. SOETOMO SURABAYA

Authors

  • Fadila Naura Safitri Program studi S1 Kedokteran, Fakultas Kedokteran, Universitas Airlangga
  • Aryati Aryati Departemen Patalogi Klinik, Fakultas Kedokteran Universitas Airlangga, Rumah Sakit Dr. Soetomo Surabaya, Indonesia
  • Musofa Rusli Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Airlangga, Rumah Sakit Dr. Soetomo Surabaya, Indonesia
  • Betty Agustina Timbunan Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Airlangga, Rumah Sakit Dr. Soetomo Surabaya, Indonesia

DOI:

https://doi.org/10.31004/prepotif.v9i3.51867

Keywords:

infeksi virus dengue, COVID-19, expanded dengue syndrome, morbiditas, mortalitas

Abstract

Infeksi virus dengue (IVD) merupakan salah satu penyakit infeksi tropis yang menunjukkan perubahan spektrum klinis pasca pandemi COVID-19. Expanded Dengue Syndrome (EDS) diketahui dapat menyebabkan komplikasi multiorgan, sementara bentuk klinis dengue lain yang sebelumnya tergolong ringan dapat menimbulkan gejala signifikan dan komplikasi berat pada pasien dengan infeksi virus dengue.  Penelitian ini bertujuan untuk mengetahui karakteristik dan gambaran komplikasi pasien dengan infeksi virus dengue pasca COVID-19. Penelitian ini merupakan penelitian deskriptif observasional dengan menggunakan data sekunder dari rekam medis pasien IVD yang dirawat di RSUD Dr. Soetomo Surabaya periode Juni 2023–Juni 2024. Dari 301 pasien, sebanyak 181 pasien mengalami komplikasi. Komplikasi tersering melibatkan sistem gastrohepatik (38%) berupa transaminitis dan hepatitis, serta sistem respirasi (35,3%) dengan dominasi efusi pleura dan ARDS. Komplikasi neurologis (11,9%) mencakup ensefalitis dan ensefalopati, sedangkan komplikasi ginjal (6,8%) didominasi oleh AKI. Komplikasi jantung (1,2%) berupa miokarditis, kardiomiopati, dan gangguan konduksi, serta hematologis (1,2%) seperti DIC dan ITP. Sebanyak 33,6% pasien mengalami trombositopenia sangat berat, dan mortalitas sebesar 4% terutama disebabkan oleh komplikasi multiorgan. Berdasarkan penelitian ini disimpulkan bahwa Ppsien IVD pasca COVID-19 menunjukkan spektrum manifestasi klinis yang bervariasi dengan komplikasi dominan pada sistem gastrohepatik dan respirasi. Identifikasi dini komplikasi EDS dan penanganan tepat diperlukan untuk menurunkan mortalitas.

References

Adissadah, A. F., Aryati, A., & Pusarawati, S. (2020). Prevalence of expanded dengue syndrome in patients with dengue virus infection at the dr. soetomo hospital surabaya in 2017 – 2018. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. [online] http://www.indonesianjournalofclinicalpathology.org/index.php/patologi/article/view/1589 [Accessed 26 April 2024]

Aryati. (2011). Buku Ajar Demam Berdarah Dengue (Tinjauan Laboratoris). Global Persada Press, Surabaya.

Anderson, E. J., Sanchez, J. E., & Harris, M. L. (2022). Increased susceptibility of pediatric populations to post-COVID dengue infections. Pediatric Infectious Disease Journal, 41(3), e78-e85. https://doi.org/10.1097/INF.0000000000003387

Chen, L., Liu, W., Zhang, Q. (2022). SARS-CoV-2 exacerbates dengue virus-induced endothelial dysfunction and liver injury. Hepatology, 75(3), 648-663. https://doi.org/10.1002/hep.32235

Dewi, N. P., et al. (2019). Risk Factors of Dengue Infection in Pediatric Population: A Case-Control Study in Surabaya. Journal of Tropical Pediatrics, 65(4), 321–328.

Dinkes Jatim. (2023). Profil Kesehatan Provinsi Jawa Timur tahun 2022. [online].

Available at: https://dinkes.jatimprov.go.id/userfile/dokumen/PROFIL KESEHATAN JATIM 2022.pdf [Accessed 26 April 2024]

Garcia, M. N., et al. (2022). Post-COVID-19 Immune Dysregulation and Its Impact on Tropical Diseases: A Scoping Review. Frontiers in Immunology, 13, 876345.

Garcia, M., Pelletier, S., Le Gall, S., & Duffy, D. (2023). Long-term lymphoid tissue alterations after SARS-CoV-2 infection. Nature Immunology, 24(5), 642-651. https://doi.org/10.1038/s41590-023-01460-z

Guzman, M. G., Alvarez, M., Rodriguez-Roche, R., Bernardo, L., Montes, T., Vazquez, S., & Halstead, S. B. (2023). Increased severity of dengue virus infections in the post-COVID-19 pandemic period: A multicenter study in the Philippines. PLoS Neglected Tropical Diseases, 17(5), e0011342. https://doi.org/10.1371/journal.pntd.0011342

Gupta, R. K., Agrawal, S., Singh, P., & Kumar, A. (2019). Hepatic manifestations in dengue fever: A prospective observational study of 1200 patients. Journal of Clinical and Experimental Hepatology, 9(3), 315-321. https://doi.org/10.1016/j.jceh.2018.12.004

Huzly, D., Hanselmann, I., & Neumann-Haefelin, C. (2016). Kinetics of dengue virus-specific IgM and IgG antibodies in primary and secondary infections. Journal of Clinical Virology, 78, 36-41. https://doi.org/10.1016/j.jcv.2016.03.002

Kemenkes. (2019). Strategi Nasional Penanggulangan Dengue 2021-2025. In Kementerian Kesehatan RI.

Kemenkes. (2021). Strategi Nasional Penanggulangan Dengue 2021-2025. In

Kementerian Kesehatan RI.

Kemenkes. (2023). Profil Kesehatan Indonesia. [online] www.kemkes.go.id.

Available at: https://p2p.kemkes.go.id/profil-kesehatan-2022/ [Accessed 26 April2024].

Kuo, C. H., Yang, S. N., Chen, P. C., & Wang, H. C. (2021). Post-COVID-19 cardiac inflammation in dengue patients: A prospective cohort study. Journal of Infection, 83(4), 412-420. https://doi.org/10.1016/j.jinf.2021.07.019

Kurniawan, A., Samsi, T. K., & Wulandari, L. (2022). Gender differences in environmental and behavioral risk factors for dengue hemorrhagic fever in urban Indonesia: A case-control study. PLoS Neglected Tropical Diseases, 16(4), e0010289. https://doi.org/10.1371/journal.pntd.0010289

Lessa, C. L. S., Hodel, K. V. S., Gonçalves, M. de S., & Machado, B. A. S. (2023). Dengue as a Disease Threatening Global Health: A Narrative Review Focusing on Latin America and Brazil. In Tropical Medicine and Infectious Disease. https://doi.org/10.3390/tropicalmed8050241

Malavige, G. N., Jeewandara, C., Ogg, G. S., & Fernando, S. (2022). Outcomes of dengue in post-viral infection cohorts in Sri Lanka. The Lancet Infectious Diseases, 22(5), 675-683. https://doi.org/10.1016/S1473-3099(21)00726-7

Mallhi, T. H., Adnan, A. S., Aftab, R. A., Khan, Y. H., & Tanveer, N. (2020). Expanded Dengue Syndrome. In Expanded Dengue Syndrome. https://doi.org/10.1007/978-981-15-7337-8

Mohanty, B., Sunder, A., & Pathak, S. (2019). Clinicolaboratory profile of expanded dengue syndrome – Our experience in a teaching hospital. Journal of Family Medicine and Primary Care. https://doi.org/10.4103/jfmpc.jfmpc_12_19

Mustafa, M., & Kiau, H. B. (2011). Management of dengue infection in adults. Malaysian Family Physician. Namitha, P. M., Dinesh, K. R., & Avinash, S. S. (2022). Clinical spectrum and outcome of expanded dengue syndrome: A retrospective study from South India. Journal of Infection and Public Health, 15(1), 123-128. https://doi.org/10.1016/j.jiph.2021.09.018

Prasetyo, R. A., Budiman, E., & Susanto, L. (2023). Higher complication risks in elderly dengue patients: A retrospective cohort study at Dr. Soetomo General Hospital. Indonesian Journal of Internal Medicine, 15(2), 145-153. https://doi.org/10.36485/ijim.v15i2.421

Pusponegoro, H. D., Sekartini, R., Soedjatmiko, S., & Hindra, I. S. (2023). Dengue encephalopathy in children: Clinical characteristics and predictors of febrile seizures. Paediatrica Indonesiana, 63(1), 12-20. https://doi.org/10.14238/pi63.1.2023.12-20

Rodrigues, R. A., Oliveira, D. N., Santos, C. C., Lima, M. H., Carvalho, E. E., & Costa, F. T. (2022). Renal complications in post-COVID dengue infections: Mechanisms of endothelial injury and cytokine storm effects. Kidney International Reports, 7(5), 1021-1033. https://doi.org/10.1016/j.ekir.2022.02.018

Salgado, D. M., Eltit, J. M., Mansfield, K., Panqueba, C., Castro, D., Vega, M. R., Xhaja, K., Schmidt, D., Martin, K. J., Allen, P. D., Rodriguez, J. A., Dinsmore, J. H., López, J. R., & Bosch, I. (2010). Heart and skeletal muscle are targets of dengue virus infection. Pediatric Infectious Disease Journal. https://doi.org/10.1097/INF.0b013e3181bc3c5b

Samanta, J., Sharma, V., Sharma, A., & Singh, S. (2020). Hepatic involvement in dengue patients with comorbid conditions: A comparative analysis. Hepatology International, 14(5), 742-751. https://doi.org/10.1007/s12072-020-10068-4

Sharma, C. M., Khanna, M., Sharma, S., & Kumar, R. (2023). Guillain-Barré syndrome following dengue infection: Molecular mimicry and autoimmune pathogenesis. Journal of Neuroimmunology, 377, 578-585. https://doi.org/10.1016/j.jneuroim.2023.578-585

Shivanthan, M. C., Navinan, M. R., Constantine, G. R., & Rajapakse, S. (2015). Cardiac involvement in dengue infection. Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.6200

Singhal, V., Jha, V., & Mathew, R. (2023). Post-COVID dengue mortality patterns in India: A multicenter study. Journal of Infection, 86(3), 256-263. https://doi.org/10.1016/j.jinf.2022.12.014

Solomon, T., Dung, N. M., Vaughn, D. W., Kneen, R., Thao, L. T. T., Raengsakulrach, B., Loan, H. T., Day, N. P. J., Farrar, J., Myint, K. S. A., Warrell, M. J., James, W. S., Nisalak, A., & White, N. J. (2021). Neurological manifestations of dengue infection. The Lancet Neurology, 20(3), 203-215. https://doi.org/10.1016/S1474-4422(20)30432-1

Talarico, L. B., Anderson, K. B., & Bromberg, S. A. (2017). Patterns of IgM and IgG antibodies in sequential dengue infections. American Journal of Tropical Medicine and Hygiene, 97(2), 452-459. https://doi.org/10.4269/ajtmh.16-0962

Tan, L. H., Raju, M. K., & Teoh, S. C. (2022). Ocular manifestations of dengue fever: Pathogenesis and clinical management. Survey of Ophthalmology, 67(3), 453-465. https://doi.org/10.1016/j.survophthal.2021.11.003

Torresi, J., Ebringer, A., & Bull, R. A. (2022). Cross-reactive immunity between dengue and SARS-CoV-2. Clinical & Translational Immunology, 11(3), e1382. https://doi.org/10.1002/cti2.1382

Tricou, V., Minh, N. N., Van, T. P., Lee, S. J., & Simmons, C. P. (2021). Timing of the critical phase in dengue illness: Implications for clinical management. PLOS Neglected Tropical Diseases, 15(8), e0009680. https://doi.org/10.1371/journal.pntd.0009680

Trung, D. T., Thao, L. T. T., Van, H. L., Kien, N. T., (2023). Impact of prior COVID-19 infection on clinical outcomes of dengue fever: A matched case-control study. PLOS Neglected Tropical Diseases, 17(1), e0011065. https://doi.org/10.1371/journal.pntd.0011065

Umakanth, M., & Suganthan, N. (2020). Unusual Manifestations of Dengue Fever: A Review on Expanded Dengue Syndrome. Cureus. https://doi.org/10.7759/cureus.10678

WHO. (2023). Global Strategy for Dengue Prevention and Control 2023–2030. Geneva: World Health Organization.

Wijaya, R. S., Andhika, R., Huang, I., Lim, M. A., & Pranata, R. (2023). The impact of prior COVID-19 infection on dengue severity: A retrospective cohort study at Cipto Mangunkusumo Hospital. BMC Infectious Diseases, 23(1), Article 482. https://doi.org/10.1186/s12879-023-08442-2

Wilder-Smith, A., Yoksan, S., & Buchy, P. (2019). Serological responses in dengue diagnosis and vaccine development. Vaccine, 37(28), 3664-3669. https://doi.org/10.1016/j.vaccine.2019.05.022

World Health Organization. (2009). Dengue guidelines for diagnosis, treatment, prevention and control. World Health Organization.

Yacoub, S., Wertheim, H., Simmons, C. P., Screaton, G., & Wills, B. (2020). Cardiovascular manifestations of the dengue shock syndrome. Clinical Infectious Diseases, 71(9), 2249-2255. https://doi.org/10.1093/cid/ciz1189

Downloads

Published

2025-12-30

How to Cite

Safitri, F. N., Aryati, A., Rusli, M., & Timbunan, B. A. (2025). PROFIL KLINIS, LABORATORIS, MORBIDITAS DAN MORTALITAS PADA PASIEN INFEKSI VIRUS DENGUE PASCA COVID-19 DI RSUD DR. SOETOMO SURABAYA. PREPOTIF : JURNAL KESEHATAN MASYARAKAT, 9(3), 10429–10445. https://doi.org/10.31004/prepotif.v9i3.51867